Literature DB >> 21422252

Protective B cell responses to flu--no fluke!

Elizabeth E Waffarn1, Nicole Baumgarth.   

Abstract

The mechanisms regulating the induction and maintenance of B lymphocytes have been delineated extensively in immunization studies using proteins and hapten-carrier systems. Increasing evidence suggests, however, that the regulation of B cell responses induced by infections is far more complex. In this study, we review the current understanding of B cell responses induced following infection with influenza virus, a small RNA virus that causes the flu. Notably, the rapidly induced, highly protective, and long-lived humoral response to this virus is contributed by multiple B cell subsets, each generating qualitatively distinct respiratory tract and systemic responses. Some B cell subsets provide extensive cross-protection against variants of the ever-mutating virus, and each is regulated by the quality and magnitude of infection-induced innate immune signals. Knowledge gained from the analysis of such highly protective humoral response might provide a blueprint for successful vaccines and vaccination approaches.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422252      PMCID: PMC3154207          DOI: 10.4049/jimmunol.1002090

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

1.  Antiviral instruction of bone marrow leukocytes during respiratory viral infections.

Authors:  Tamar Hermesh; Bruno Moltedo; Thomas M Moran; Carolina B López
Journal:  Cell Host Microbe       Date:  2010-05-20       Impact factor: 21.023

2.  CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection.

Authors:  Byung O Lee; Javier Rangel-Moreno; Juan E Moyron-Quiroz; Louise Hartson; Melissa Makris; Frank Sprague; Frances E Lund; Troy D Randall
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

Review 3.  Regulation of autoreactive B cell responses to endogenous TLR ligands.

Authors:  Ana Maria Avalos; Liliana Busconi; Ann Marshak-Rothstein
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 4.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

5.  Influenza viruses as lymphocyte mitogens. II. Role of I-E molecules in B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes.

Authors:  A A Scalzo; E M Anders
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

6.  Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice.

Authors:  S Nisitani; T Tsubata; M Murakami; T Honjo
Journal:  Eur J Immunol       Date:  1995-11       Impact factor: 5.532

7.  B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion.

Authors:  David Savitsky; Kathryn Calame
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

8.  Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Authors:  Takeshi Ichinohe; Heung Kyu Lee; Yasunori Ogura; Richard Flavell; Akiko Iwasaki
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

9.  Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

Authors:  Felix Geeraedts; Nadege Goutagny; Veit Hornung; Martina Severa; Aalzen de Haan; Judith Pool; Jan Wilschut; Katherine A Fitzgerald; Anke Huckriede
Journal:  PLoS Pathog       Date:  2008-08-29       Impact factor: 6.823

10.  An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions.

Authors:  Mark Y Sangster; Janice M Riberdy; Maricela Gonzalez; David J Topham; Nicole Baumgarth; Peter C Doherty
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

View more
  52 in total

1.  Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.

Authors:  Yuan Fang; David Banner; Alyson A Kelvin; Stephen S H Huang; Christopher J Paige; Steven A Corfe; Kevin P Kane; R Chris Bleackley; Thomas Rowe; Alberto J Leon; David J Kelvin
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

Review 2.  B Cell Activation and Response Regulation During Viral Infections.

Authors:  Jonathan H Lam; Fauna L Smith; Nicole Baumgarth
Journal:  Viral Immunol       Date:  2020-04-23       Impact factor: 2.257

Review 3.  Causes, consequences, and reversal of immune system aging.

Authors:  Encarnacion Montecino-Rodriguez; Beata Berent-Maoz; Kenneth Dorshkind
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

4.  Intranasal immunization with influenza antigens conjugated with cholera toxin subunit B stimulates broad spectrum immunity against influenza viruses.

Authors:  Junwei Li; Maria T Arévalo; Yanping Chen; Olivia Posadas; Jacob A Smith; Mingtao Zeng
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

Review 5.  Evaluating the case for trivalent or quadrivalent influenza vaccines.

Authors:  David Baxter
Journal:  Hum Vaccin Immunother       Date:  2016-07-19       Impact factor: 3.452

6.  T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.

Authors:  Shalini Sharma; Aarthi Sundararajan; Amol Suryawanshi; Naveen Kumar; Tamara Veiga-Parga; Vijay K Kuchroo; Paul G Thomas; Mark Y Sangster; Barry T Rouse
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-03       Impact factor: 11.205

7.  Antibody responses to influenza A(H1N1)pdm infection.

Authors:  Steph Wraith; Raffael Nachbagauer; Angel Balmaseda; Daniel Stadlbauer; Sergio Ojeda; Arvind Rajabhathor; Roger Lopez; Andrea F Guglia; Nery Sanchez; Fatima Amanat; Lionel Gresh; Guillermina Kuan; Florian Krammer; Aubree Gordon
Journal:  Vaccine       Date:  2020-05-07       Impact factor: 3.641

8.  Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.

Authors:  Katherine A Richards; Francisco A Chaves; Shabnam Alam; Andrea J Sant
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

9.  Adjuvant solution for pandemic influenza vaccine production.

Authors:  Christopher H Clegg; Richard Roque; Neal Van Hoeven; Lucy Perrone; Susan L Baldwin; Joseph A Rininger; Richard A Bowen; Steven G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 10.  Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

Authors:  K Kai McKinstry; Richard W Dutton; Susan L Swain; Tara M Strutt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-05-25       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.